*EMBARGOED All research presented at the 2020 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Monday, October 26, 2020, at 8:00 am EDT.
P0419 Diarrhea Is Associated With Increased Disease Severity in COVID-19: Systematic Review and Meta-Analysis
Author Insight from Subash Ghimire, MD, Guthrie/Robert Packer Hospital
What’s new here and important for clinicians?
Global pandemic caused by SARS-CoV-2 virus [COVID-19 infection] has caused a major public health problem. Recently published literature has focused on increasing prevalence of gastrointestinal symptoms of COVID-19. Through systematic review and meta-analysis, we looked at prevalence of diarrhea in different severities of COVID-19. We included nine published studies which reported data on diarrhea based on severity of COVID-19, including 2192 patients. There were 1751 patients in non-severe disease group and 441 patients in severe group. Patient with severe disease had higher odds of diarrhea as one of the presenting symptoms (OR 1.63, 95% CI 1.11- 2.38, p= 0.01).
What do patients need to know?
Our findings show that diarrhea is significantly associated with severe disease in COVID-19. Presence of diarrhea can have prognostic value in COVID-19.
Subash Ghimire, MD, Guthrie/Robert Packer Hospital
drsubash01 [at] gmail [dot] com
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi [dot] org or by phone at 301-263-9000.